Thalamic Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-05-08
Clinical Trial Update: ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors [Phase 2]
Completed Phase 2 trial evaluating ANGIOCOMB, an antiangiogenic therapy, in pediatric patients with diffuse brainstem and thalamic tumors.